Genmab — Juni 2019

[LyngeInv]

Deres app iøvrigt også super fed OG gratis...

[kkjoel]

Åhh, før sørensens da - noget af en fejlkrydslæsning. I har alle Yahoo problemer - som jeg; det er Google finance, der HELLER IKKE har virket et par dage, i hvert fald på på dk-aktier.

[henrik48]

Måske er det NASDAQ der har lukket for dem...men lyder mærkeligt

[transalp]

It looks like a temporary data feed issue with some international exchanges. I’m investigating.

.. var det svar jeg fik fra "my portofolio" ang manglende kurser i to dage..

[E_L]

Nature Reviews Clinical Oncology https://www.nature.com/articles/s41571-019-0244-y https://sci-hub.tw/https://www.nature.com/articles/s41571-019-0244-y

[E_L]

https://sci-hub.tw/https://www.nature.com/articles/s41571-019-0244-y

[E_L]

Durie starts a bit slow, but very interesting further on with Dr. Joseph Mikhael + Dr. Philippe Moreau https://www.myeloma.org/videos/frontline-therapy-imwg-amsterdam-2019

[Solsen]

Dejligt at være i +1200 igen

[mobbyduck1]

hvad forventer vi i morgen, alt over 150 mio er vel fint?

[E_L]

Relapse Therapies also interesting , a bit on Isa and Dara https://www.myeloma.org/videos/relapse-therapies-imwg-amsterdam-2019

[E_L]

“With Dara coming earlier…. Where Isa is gonna fit is a little bit chalenging , because, to be honest, almost everybody will have had Daratumumab, if not in frontline then first relapse. And we dont really know how effective Isa is once you failed Dara.”

[Bulder]

Noted that there is a developement going on with sc isa!

[Bulder]

and thx for those 2 videos E L

[Hen]

Investtech-analysevideo fra i går: https://play.borsen.dk/klip/5d073ad3595ab4f00a333654

[E_L]

yes, he also said 'it won't be as quickly as daratumumab obviously', not sure why. Anyway, currently the speed is 1 of Isa's few advantages; that will disappear with Dara SC

[E_L]

it is funny how these doctors speak as if it is already approved sometimes... ("now that we have SC"...)

[E_L]

i also thought it was interesting them talking about Dara monthly maintenance possibly switching back to weekly in case of deterioration

[Bulder]

Maybe they already started off label .- it's not a new drug, only way of adm.

[E_L]

yes, maybe. Rajkumar sort of seemed to imply that also with D-VRd and D-VTd. Will be interesting to see US volume later this year...

[LyngeInv]

Fra Medwatch: Det tyske biotekselskab Biontech er sammen med Genmab klar til det første forsøg i mennesker med et lægemiddel, som de to selskaber udvikler i fællesskab.